Quidel | QDEL - Operating Expenses


Quidel reported $760.9M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Abbott USD 9.21B 17M Dec/2025
Agilent USD 1.42B 57M Sep/2025
Avanos Medical USD 156.13M 2.7M Dec/2025
Becton, Dickinson and Co. USD 4.59B 476M Dec/2025
Bruker USD 900.9M 124.3M Dec/2025
Cerus USD 34.78M 2.98M Dec/2024
Charles River Laboratories USD 918.41M 2.49B Dec/2025
Danaher USD 5.34B 45.74B Dec/2025
Exact Sciences USD 875.74M 62.51M Sep/2025
Haemonetics USD 134.99M 1.26M Dec/2025
Hologic USD 349.4M 447.1M Dec/2025
Illumina USD 903M 69M Dec/2025
IQVIA Holdings USD 1.69B 4.47B Dec/2025
Merit Medical Systems USD 341.54M 6.11M Sep/2025
Mettler Toledo International USD 777.8M 42.3M Dec/2025
Myriad Genetics USD 229M 3.4M Sep/2025
Neogen USD 230.07M 4.79M Sep/2025
OraSure Technologies USD 23.07M 4.36M Sep/2024
Pacific Biosciences Of California USD 74.08M 107.7M Sep/2024
Quidel USD 760.9M 1.28B Dec/2025
Revvity USD 626.22M 25.62M Dec/2025
STAAR Surgical USD 69.04M 8.29M Jun/2025
Thermo Fisher Scientific USD 9.91B 867M Dec/2025
Waters USD 661.85M 1.67B Dec/2025